Top-Event
Top
The discussion will highlight the opportunities of international collaboration in that industry. It will showcase the development in the international as well as domestic medical technology industry in QLD. Very relevant topic considering that the current regulatory framework for medical devices under the Therapeutic Goods Administration is under review.
The panel includes:
- Prof Michael Schuetz, FRACS, FA Orth, Director Jamieson Trauma Institute (moderator)
- Clare Blain, CEO Life Sciences Queensland Limited
- Robert Frigg, Chairman 41medical, Switzerland
- Thomas Samyn, KLS Martin Group, Germany
Supported by
